Ciba-Geigy/NNP Ltd./NNP and/CC Chiron/NNP Corp./NNP said/VBD they/PRP extended/VBD their/PRP$ offer/NN for/IN Connaught/NNP BioSciences/NNP Inc./NNP ,/, valued/VBN at/IN #/CD million/CD Canadian/JJ dollars/NNS -LRB-/-LRB- US$/$ #/CD million/CD -RRB-/-RRB- to/TO Oct./NNP #/CD ./.
The/DT companies/NNS earlier/RBR said/VBD they/PRP did/VBD n't/RB want/VB to/TO raise/VB their/PRP$ offer/NN to/TO match/VB a/DT rival/JJ bid/NN by/IN Institut/NNP Merieux/NNP S.A./NNP of/IN C$/$ #/CD a/DT share/NN ,/, or/CC C$/$ #/CD million/CD ./.
But/CC they/PRP said/VBD the/DT C$/$ #-a-share/JJ bid/NN ,/, which/WDT was/VBD due/JJ to/TO expire/VB Monday/NNP ,/, may/MD still/RB be/VB extended/VBN or/CC varied/VBN ./.
Merieux/NNP ,/, a/DT vaccine/NN manufacturer/NN based/VBN in/IN Lyon/NNP ,/, France/NNP ,/, is/VBZ #%-held/JJ by/IN French/JJ state-owned/JJ Rhone-Poulenc/NNP S.A/NNP ./.
Ciba-Geigy/NNP is/VBZ a/DT major/JJ pharmaceutical/JJ concern/NN based/VBN in/IN Basel/NNP ,/, Switzerland/NNP ./.
Chiron/NNP ,/, another/DT pharmaceutical/JJ concern/NN ,/, is/VBZ based/VBN in/IN Emeryville/NNP ,/, Calif/NNP ./.
Connaught/NNP is/VBZ a/DT biotechnology/NN research/NN and/CC vaccine/NN manufacturing/NN concern/NN ./.
Institut/NNP Merieux/NNP 's/POS bid/NN for/IN Toronto-based/JJ Connaught/NNP has/VBZ run/VBN into/IN problems/NNS with/IN the/DT Canadian/JJ government/NN ,/, which/WDT told/VBD Merieux/NNP last/JJ week/NN that/IN it/PRP was/VBD n't/RB convinced/VBN that/IN the/DT proposed/JJ acquisition/NN would/MD be/VB of/IN ``/`` net/JJ benefit/NN ''/'' to/TO Canada/NNP ./.
Merieux/NNP officials/NNS are/VBP expected/VBN to/TO meet/VB with/IN federal/JJ officials/NNS in/IN Ottawa/NNP today/NN to/TO discuss/VB the/DT decision/NN ./.
